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Abstract
Delirium and depression are complex neuropsychiatric syndromes that are common in the elderly 
and associated with a variety of poor healthcare outcomes. Accurate detection is key to providing 
optimal care for these conditions but is complicated by their considerable clinical overlap. This 
includes shared symptom profiles as well as comorbidity. Careful assessment of symptom 
character as well as the context and course of disturbances can allow for more accurate diagnosis. 
Prior depressive illness is a common finding in patients with delirium, while depressive illness is a 
recognised sequel of delirium. Evidence points to similar pathophysiological mechanisms 
involving disturbances in stress and inflammatory responses, monoaminergic and melatonergic 
functions, that in turn point to avenues for therapeutic intervention. Development of better tools 
for systematic assessment for delirium and depression in populations at high risk by virtue of age, 
diminished cognitive reserve and frailty is a key target to achieve improved healthcare outcomes.
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Introduction
Delirium is aserious acute neuropsychiatric disorderthat is common in hospitalised 
populations, occurring in approximately 1 in 5 general hospital admissions.1,2 It is 
associated with significant adverse outcomes including prolonged hospitalisation, increased 
nursing home placement, functional decline, long term cognitive impairment and increased 
mortality.3-5 Despite this, it remains understudied and poorly recognised in everyday 
practice with typically 50% of cases missed or misdiagnosed across healthcare settings.6 
Although characterised as a neurocognitive disorder,7 delirium isa complex syndrome 
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consisting of a range of cognitive and non-cognitive features.8 The non-cognitive features 
include disruptions to sleep-wake cycle, motor activity as well as disturbances in mood and 
affective expression.9,10
Major depression is common in the elderly with point prevalence estimated at 4·6-9·3% with 
an additional 2-3 times as many (4·5-37·4%) experiencing sub-threshold depressive 
symptomatology.11 Hospitalised samples indicate rates as high as 45% of elderly 
inpatients.12 A variety of medical morbidities are associated with elevated risk for 
depression (e.g. Parkinson’s disease, Cerebrovascular disease, Diabetes) with depression 
prevalent in 20- 30% of patients with dementia,11 and although late life depression is 
associated with a twofold increase in dementia risk, it remains unclear whether it is an actual 
risk factor for dementia or a prodromal marker.13,14
Depression and delirium are potentially related in several ways.Overlap may indicate 
comorbidity in patients who are frail and/or share risk factors for neuropsychiatric 
disturbances and are thus prone to complex multiple morbidity. It may also merely reflect a 
lack of phenomenological precision that occurs with syndromal diagnoses. Conversely, the 
widespread disruption of neural networks that characterises delirium may also incorporate 
affective centres in vulnerable or predisposed subjects such that the presence of prominent 
affective features may assist in identifying a subset of patients who can benefit from targeted 
therapeutic interventions. Similarly, patients with mood disorders can have prominent 
cognitive disturbances that may extend to include the range of features that characterise 
delirium. The frequency of mood disorders and delirium, especially in elderly populations 
with pre-existing cognitive impairments is such that a combination of these factors is likely 
to underpin the perceived overlap, but a better understanding of this interrelationship offers 
the prospect of improved outcomes in everyday clinical practice.
The purpose of this review is to examine the literature relevant to delirium and depression. 
In particular, we focus on the extent of the overlap, possible explanations for the inter-
relationship and its implications for clinical practice and research efforts.
Search Strategy and Selection Criteria
A search of Medline was conducted for English language publications between January 1, 
1980 and January 1, 2014. Key search terms included ‘delirium’, ‘depression’, ‘confusion’, 
‘affect’, ‘mood’, ‘affective’, ‘mania’ and ‘mood disorder’. 2597 articles were identified. The 
search was refined to include only studies of adult populations and where the key search 
terms were in major headings of the publication, which identified 429 publications. Relevant 
articles were identified from a review of these abstracts. Age limited to adults. Case reports 
and reviews were excluded. A hand-search of references listings of the selected papers was 
used to identify any additional publications (See Figure 1 for search strategy and results).
Epidemiology
Affective symptoms are common to both depression and delirium with affective lability 
reported in 43-86% of all episodes of delirium.8,10,15 More sustained mood disturbances in 
delirium have also been reported; Leonard et al16 found that core depressive symptoms such 
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as low mood and anhedonia were frequent in delirious subjects - 54% of subjects had one of 
these features and 38% had both. Farrell and Ganzini17 reported low mood, anhedonia, 
feelings of worthlessness or guilt, loss of appetite and sleep disturbance in over 50% of the 
delirious subjects who had been referred with suspected depression. Moreover, 52% had 
frequent thoughts of death and 24% had thoughts of suicide.
Similarly, depressive illness frequently includes many of the cognitive disturbances that 
occur in delirium, especially in older subjects. The most consistent deficits occur with 
respect toexecutive function, processing speed, selective attention and the acquisition and 
retrieval of new information.18
Other work has explored the overlap condition of delirium and depression. This occurs 
commonly in hospitalized older persons. Based on estimates from previous studies, 
approximately 5-12% of older hospitalized patients meet diagnostic criteria for both 
conditions, with an even greater number having symptoms of both.16,19 However, large-scale 
epidemiologic studies to document the co-occurrence of these conditions are lacking.
The adverse outcomes associated with delirium have been well documented, including 
increased mortality, institutionalization, healthcare costs, functional and cognitive decline.1,3 
Mortality risk at three months increased by 11% for every 48 hours of active delirium in 
elderly medical inpatients20 thus highlighting the importance of timely diagnosis and 
treatment. Depressive symptoms are an important factor in missed or delayed diagnosesand 
likely contributed to poor outcomes in these prior studies. Moreover, the overlap syndrome 
has been associated with a strikingly worse prognosis than either condition on its own. In a 
large prospective cohort of 456 medical patients, Givens et al19 documented that patients 
with the overlap syndrome of delirium and depression had a 5-fold increased risk of nursing 
home placement or mortality, and 3-fold increased risk of functional decline at one-month 
than patients with neither condition.Both delirium and depression contributed independently 
and additively to the adverse outcomes.
Diagnostic considerations
Diagnostic criteria for delirium and depression appear in Table 1
Both delirium and depression are syndromally defined and include cognitive and 
neuropsychiatric elements. However, the emphasis differs with delirium considered 
primarily a neurocognitive disorder, while depressive illness has sustained mood disturbance 
at its core.7,21 This distinction is complicated by the fact that within the concepts of delirium 
and mood disorder there exist a range of presentations that include agitated depression, 
hyperactive delirium, psychomotor retarded depressive illness, hypoactive delirium, Bell’s 
mania, and depressive pseudo-dementia that describe combined mood and cognitive 
elements. While affective disturbances are acknowledged to occur with delirium in DSM-5 
and ICD 10 diagnostic criteria (e.g., anxiety, fear, depression, irritability, anger, euphoria and 
apathy), they are not considered core elements. Moreover, most delirium assessment tools 
have limited inclusion of affective symptoms to avoid confounding, other than lability of 
affect (DRS-R98),22 inappropriate mood (Intensive Care Delirium Screening Checklist 
(ICDSC)),23 and apathy (Delirium-O-Meter).24
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The GDS-15 is the most commonly used scale for depressive symptoms in the studies we 
identified. It has been widely used in studies of elderly at risk of depression25-26 but 
diagnostic accuracy is lower in patients with mild-moderate cognitive impairment and the 
self-report nature is problematic in patients with dementia.27 The Cornell Scale for 
Depression in Dementia (CSDD)28 is a clinician rated scale that is more accurate than the 
GDS for assessment of depression in subjects with significant cognitive impairment29 but 
lacks sensitivity to change which impacts upon its suitability for serial assessments. Future 
studies of depressive symptoms in delirious subjects require greater clarity regarding optimal 
assessment methods that account for cognitive impairment and comorbid physical 
conditions.
Assessment in clinical practice
Although the symptoms of delirium and depression are relatively lacking in specificity, 
careful assessment of the context of symptoms can allow for accurate attribution whereby 
delirium is typically more acute in onset and more likely to be linked to acute physical 
illness, while depressive symptoms typically develop more gradually (weeks) and are linked 
to psychological stressors. Depressive illness may exhibit diurnal fluctuation in symptom 
intensity but rarely fluctuate with the intensity or rapidity of delirium. Disturbances to mood 
are typically more sustained in depressive illness and where disturbances of consciousness 
occur, these tend to be less profound compared to the qualitative disturbance of delirium that 
impairs awareness of the immediate environment. Neurobehavioural and psychotic 
symptoms are also common to both depression and delirium but their character and context 
typically differs; in delirium psychotic features are often simple and relate to the immediate 
environment, while psychotic mood disorders classically include complex mood-congruent 
psychotic features involving themes of guilt or nihilism. Sleep-wake cycle is the most 
common non-cognitive function disturbed in delirium and is reported in 97-99% of all 
delirious episodes.8,10 Moreover, the character of disturbances differs with sleep-wake cycle 
fragmentation or even complete reversal in approximately three quarters of delirious 
patients, while depression more typically includes initial or late insomnia.As such, careful 
history taking, augmented by a collateral source where possible, aligned to thorough 
examination and investigation for acute medical conditions are crucial to accurate diagnosis. 
Specific assessment tools such as the DRS-R98 and / or EEG can assist these efforts in more 
complex cases.30 Table 2 outlines relatively distinguishing and overlapping features of 
delirium and depression.
There is considerable overlap in presentation between hypoactive delirium and depression 
with psychomotor retardation with both including decreased amount and speed of activity 
and speech, though the onset of such symptoms may be more insidious in depression.31 This 
overlap is important as the prognosis of hypoactive delirium is generally considered to be 
worse than for other clinical subtypes.32 Agitation, which may be a feature of delirium, is 
more frequently associated with late life depression33 while conversely, increasing age is 
associated with relatively hypoactive presentations of delirium.
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Misdiagnosis of delirium as depression
Delirium is commonly the actual diagnosis in referrals to consultation-liaison psychiatry for 
assessment of suspected depression, with reports ranging from 6% to 52%cases representing 
such misdiagnoses.17,34-36 Although these studies do not adequately account for possible 
comorbidity and include many complex diagnostic challenges, equally,referrals to 
psychiatric consultation liaison services represent a small proportion of cases of delirium 
that occur in hospital settings and the full extent of misdiagnosis is likely to be considerably 
greater than that described in these studies.
Misdiagnosis reflects a range of factors including limited awareness of delirium as an entity, 
the absence of formal screening in everyday practice, as well as the complexity of the 
syndrome which is typically highly fluctuating and can include presentations (e.g. 
hypoactive clinical subtype) that are phenomenologically very similar to depressive illness. 
Moreover, there is a lack of consensus as to the best scales to use for assessment and 
diagnosis.37 Factors that have been directly linked to misdiagnosis include atypical 
presentation, inexperience of the diagnosing clinician and a documented past psychiatric 
diagnosis.35,38 In addition, womenwith misdiagnosed delirium are more commonly labelled 
asdepression, while men are more likely to receive an unspecified diagnosis.35
Distinguishing the two conditions can be difficult, especially where delirium presents with 
hypoactive features. The presence of depressive symptoms in the absence of core delirium 
symptoms suggest a diagnosis of depressive illness, whereas, presence of depressive 
symptoms in a patient with delirium carry less diagnostic certainty and may reflect mood 
changes in delirium rather than a discrete depressive illness.16,32,39 Other confounding 
factors are the overlap between symptoms of physical illness and depression or delirium, 
such as weight loss, fatigue, reduced energy, reduced appetite and psychomotor retardation, 
which may occur independently of depression or delirium. Other reasons for the 
misdiagnosis are the overlap of the two syndromes, as documented in recent studies.
Etiologic considerations
Depression as a risk factor for delirium
At least 17 previous studies have examined depression as a risk factor for delirium (See 
Appendix Table 2). Sample sizes ranged from 34 – 11,745 patients. Fifteen studies included 
general adult populations and 16 focused on older adult populations (aged 60+). Study 
settings included postoperative (n=12), general medical (n=4), and nursing home (n=1). The 
increased risk for delirium in patients with depression ranged from1·3 to 9-fold.40,41 Active 
depressive illness42-44 and number of pre-operative depressive symptoms on the GDS-15 
influenced both incidence and duration of postoperative delirium.45 Both a history of 
depression and presence of subclinical levels of depression are risk factors for delirium.40 
Specific symptoms of depression may contribute to increased risk of delirium. Psychological 
symptom burden rather than physical symptom burden was associated with an increased 
incidence and longer course of postoperative delirium.46 Dysphoric mood and hopelessness 
rather than withdrawal and apathy were more strongly associated with delirium.47
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Two previous studies did not support current depression as a risk factor for delirium.48,49 
However, the latter study did find that a past psychiatric diagnosis, most commonly 
depression, was predictive of delirium.
Delirium as a risk factor for depression
Seven prospective studies examined delirium as a risk factor for subsequent depression. 
These studies examined diverse populations, including elderly hip fracture (n=4), cardiac 
surgery (n=1), stem cell transplant (n=1), and burn unit (n=1) patientsfor follow-up periods 
ranging from two-weeks to two years. Six studies found a positive association between 
delirium and subsequent depressive symptoms. Dolan et al50 reported those with delirium 
were 1·5 times more likely to exhibit depressive symptoms at two year follow up. Three 
studies reported significantly higher scores on depression rating scales in the delirious 
groups at follow up between one and four months post delirium.51-3
Pathophysiological overlap
There have been no studies directly assessing the relationship between etiological and 
biological parameters and symptoms of delirium and depression. As such, possible overlap 
with respect to pathophysiology is inferred from our knowledge of each condition 
separately. A variety of physiological mechanisms are implicated in delirium, most of which 
are also thought to be relevant to depression. This reflects the complexity of both conditions 
with widespread disruption of neural networks.These overlapping neurobiologies may 
explain the close inter-relationship between the conditions.
The principal neurophysiological disturbances linked to delirium relate to alterations in 
monoamine neurotransmission and abnormal stress and inflammatory responses – all of 
which are also proposed as mechanisms in depressive illness. In delirium, indirect evidence 
from studies of causative factors and treatment effects, along with more direct evidence from 
cerebrospinal fluid studies has implicated dopaminergic-cholinergic imbalanceas a common 
final neural pathway.54,55 Other evidence points towards aberrant interactions between 
inflammatory mechanisms and thelimbic-hypothalamic-pituitary-adrenocortical axis 
(LHPA) in delirium. The effect of peripheral inflammatory mediators on brains already 
compromised by the effects of aging or dementia is greater than in less compromised states. 
In support, high levels of plasma cortisol,56 and dexamethasone non-suppression57 have 
been reported in deliriumand may contribute to a prolonged or exaggerated stress 
response.58,59 Moreover, studies have linked altered expression of various cytokines to 
delirium.60 Similarly, disturbed monoamine function and over-activity of the hypothalamic-
pituitary-adrenal axis (HPA) are well-established mechanisms in the pathophysiology of 
depression61 with considerable evidence for the role of cytokines and inflammatory 
processes in depression.62
The fluctuating course and disturbed sleep and motor activity in delirium suggest disruption 
of circadian function. Disturbedmelatonergic activity hasbeen reported in delirium.63,64 
Vulnerability to delirium proneness may be elevated in those with compromised circadian 
regulation whereby acute physiological stress can precipitate a cycle of escalating circadian 
disruption manifesting as a delirious episode.65 Circadian disturbances are also linked to 
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depressive illness and supported by the use of melatonergic antidepressants and symptoms 
such as diurnal mood variation and sleep disturbance. However, in both conditions circadian 
changes may be secondary to impaired perception of environmental zeitgebers that regulate 
circadian function.66
A proposed model for the relationship between delirium and depression is shown in Figure 
2. Ultimately, a combination of (i) host factors such as baseline cognition, physical status 
and genetic predisposition (ii) altered stress axis and systemic inflammatory responses and 
(iii) the nature of the insult (physical stressors linked to delirium with psychological more 
likely to result in depression) render the individual susceptible to developing 
neuropsychiatric morbidity withdepression, delirium or, in the most vulnerable individuals, 
features of both-the ‘overlap syndrome’.
Therapeutic considerations
Thesubstantial overlap between delirium and depressionhas important implications for 
management. Accurate, timely diagnosis of delirium is especially urgent because it is a 
frequently a manifestation of serious underlying morbidity. Moreover, pharmacological 
intervention warrants careful consideration of whether mood disturbance is part of delirium 
(whichmay be best managed non-pharmacologically by focusing upon treatment of the 
delirium and its underlying cause) versus a comorbid or primary diagnosis of 
depression.Where a discrete depressive illness is evident, anti-depressantagents with 
anticholinergic properties should be avoided as they may aggravate delirium symptoms. 
Older antidepressant agents (such as tricyclic agents) have well recognised anticholinergic 
effects, but the anticholinergic potential of newer agents can be underestimated -paroxetine, 
for example, has greater propensity for anticholinergic side effects in comparison to other 
selective serotonin reuptake inhibitors.67
Patients with a significant degree of overlap between delirium and depressive symptoms 
may represent a sub-group of patients that benefit from treatment targeted at both conditions, 
although this is an important area for future clinical trials. The circadian disturbance 
apparent in delirium and depression may prove a useful target of intervention. Al-Aama et 
al68 demonstrated a useful effect of melatonin in the prevention of delirium, while Hatta and 
colleagues69 found a marked reduction in delirium incidence among elderly general medical 
and ICU patients treated prophylactically for a week with a nocturnal dose of the melatonin 
agonist ramelteon. Melatonergic agents such as agomelatine are already commonly used in 
depression.68 ECTremains an important treatment option for severe and / or treatment 
resistant depressive illness70 and, although it has been suggested as a treatment for resistant 
delirium tremens, it is not generally recommended in the treatment of delirium.
Other aspects / controversies
Our understanding of the overlap between depression and delirium can be enhanced by large 
studies that focus upon longitudinal assessment of both syndromal illness as well as 
individual neuropsychiatric and cognitive disturbances that can occur in these conditions. 
Such work can clarify not only the trueextent of overlap between these conditions, but also 
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allow for the identification of features that are relatively specific for each state. In turn, this 
information can inform efforts to optimally assess for depressive symptoms in patients with 
high rates of neurocognitive disorders such as delirium and dementia. The limitations of the 
GDS and CSDD emphasise the need for alternate methods for assessment, including tools 
that are tailored specifically for this purpose.
Although both delirium and depression can include cognitive impairment, the extent to 
which these compare remains unclear. The exact nature of cognitive impairments in 
depressive illness is unclear and includes a range of possible explanations, with some studies 
suggesting that the psychomotor retardation and slowed processing speed in depression may 
account for some of the apparent cognitive impairment.71 Clarifying how cognition is 
differently affected in delirium versus depression can inform efforts to reliably identify these 
conditions as many aspects of cognitive function are particularly suited to systematic and 
reliable assessment.
Important caveats to note in interpretation of studies assessing the role of depression as a 
risk factor for delirium (and vice versa) is the need to account more consistently for the 
presence of pre-existing depressive illness and the confounding effect of shared risk factors 
in the form of physical and psychological stressors and vulnerabilities conferred by 
cognitive impairment and frailty, as these have not been adequately examined or adjusted for 
in prior work. Dissecting such relationships requires detailed longitudinal studies of patient 
populations who are at risk for these conditions.
Recent studies have highlighted the prognostic significance of interactions between delirium 
and depression. These findings may reflect a number of possible mechanisms; (i) the 
additive effects of comorbidity with additional neuropsychiatric burden and more 
widespread CNS dysfunction, (ii) combined symptoms may reflect the impact of physical 
and psychological stressors on a functionally more vulnerable CNS with diminished 
neuronal reserve, (iii) depressive states with prominent cognitive disturbance are typically at 
the more severe end of the affective spectrum, and (iv) delirium characterised by prominent 
symptoms of mood disturbance may reflect a more prognostically-severe form of the 
condition. Further research can specifically explore these possibilities which in turn can 
inform therapeutic efforts.
Most of the literature examining affective disorders and delirium focuses on depressive 
features. However, at the opposite end of the spectrum, ‘delirious mania’ is defined as ‘a 
syndrome of acute onset of the excitement, grandiosity, emotional lability, delusions and 
insomnia characteristic of mania, with the disorientation and altered consciousness 
characteristic of delirium’.72 Lee et al,73 in a small case series found that delirious and 
manic symptoms resolved at different rates. Weintraub and Lippmann74 describedpossible 
explanations for delirious mania in elderly patients including delirium mimicking a 
presentation of mania and delirium evolving into mania. However, the relationship between 
delirium and mania remains imprecisely defined and requires more systematic study.
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Conclusions
Although affective changes and cognitive impairment arewell-recognisedelements of both 
delirium and depressive illness, these disorders are typically considered as distinct entities. 
A significant amount of comorbidity is expected due to the high prevalence of delirium, 
depression and other causes of cognitive impairment in elderly populations, but the 
relationship between depression and delirium may extend to include more complex 
interactions, including shared aetiological and pathophysiological mechanisms. Both 
conditions are syndromally defined which may account for some phenomenological overlap 
and detailed longitudinal studies exploring affective and cognitive symptoms before, during, 
and after delirium are needed to clarify features that are relatively distinguishing of mood 
versus delirious states. These distinguishing features need to be emphasised in assessment 
procedures used in the study of delirium, as well as in more general studies of 
neuropsychiatric profile in populations at high risk of these conditions. Moreover, 
Identifying precise symptoms of overlap and the temporal sequence of symptoms can help to 
distinguish co-morbidity and causal relationships. Prognostically, clinical presentations that 
include elements of both states are more likely to be linked to adverse outcomes such that 
careful consideration is needed to identify optimal management responses in everyday 
clinical practice.
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PANEL
Pearls / take home messages
• Depression and delirium are common complications in hospitalised elderly 
and account for considerable morbidity and mortality
• Depression and delirium often co-exist and act as risk factors for each other 
but their distinction is important in identifying optimal treatment
• Because of their common overlap, in the hospital setting, the clinician should 
rule-out delirium in any patient suspected of depression
• Careful history taking that focuses upon the context and character of 
symptoms, complemented by focused investigation can allow for accurate 
diagnosis in the majority of cases
• Where present, symptoms of delirium tend to dominate and take diagnostic 
precedence as delirium frequently indicates serious and urgent physical 
morbidity
• In older persons, avoid treatment of depression with highly anticholinergic 
agents which may aggravate cognitive impairment or co-occurring delirium
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Figure 1. 
Process of article selection
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Figure 2. 
Proposed common pathway of depression and delirium
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Table 1
DSM-5 Criteria for Major Depressive Disorder and Delirium
DSM-5 Criteria for Major Depressive Disorder DSM-5 Criteria for delirium
A. Five or more out of nine symptoms (including at least one 
of depressed mood and loss of interest or pleasure) in the 
same 2-week period. Each of these symptoms represents 
a change from previous functioning.
1. Depressed mood (subjective or observed)
2. Loss of interest or pleasure
3. Change in weight or appetite
4. Insomnia or hypersomnia
5. Psychomotor retardation or agitation 
(observed)
6. Loss of energy or fatigue
7. Worthlessness or guilt
8. Impaired concentration or indecisiveness
9. Thoughts of death or suicidal ideation or 
attempt
B. Symptoms cause significant distress or impairment
C. Episode not attributable to a substance or medical 
condition
D. Episode not better explained by a psychotic disorder
E. There has never been a manic or hypomanic episode
A. A disturbance in attention (i.e., reduced ability to 
direct, focus, sustain, and shift attention) and 
awareness (reduced orientation to the environment).
B. The disturbance develops over a short period of time 
(usually hours to a few days), represents a change 
from baseline attention and awareness, and tends to 
fluctuate in severity during the course of a day.
C. An additional disturbance in cognition (e.g. memory 
deficit, disorientation, language, visuospatial ability, 
or perception).
D. The disturbances in Criteria A and C are not better 
explained by a pre-existing, established or evolving 
neurocognitive disorder and do not occur in the 
context of a severely reduced level of arousal, such 
as coma.
E. There is evidence from the history, physical 
examination or laboratory findings that the 
disturbance is a direct physiological consequence of 
another medical condition, substance intoxication or 
withdrawal, or exposure to a toxin, or is due to 
multiple etiologies
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Table 2
Distinguishing and overlapping features of delirium and depression
Highly distinguishing features of delirium Overlapping features
Fluctuating course Affective changes
Acute onset Sleep disturbance
Altered consciousness Underactivity
Marked Inattention Apathy
Underlying physical cause Agitation
Disorientation Impaired speed of information processing
Disorganised thinking Delusions / hallucinations
Poor comprehension Impaired memory
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Table 3
Key areas for future research focus
Epidemiology:
Large studies across therapeutic settings and age groups to ascertain the extent of overlap between delirium and mood disorders, and exploring 
the impact of each separately and in combination upon healthcare outcomes
Diagnosis and Assessment / Phenomenology:
Identification specific features (both cognitive and neuropsychiatric) of delirium and depression that are relatively distinguishing of the 
conditions, and which can be incorporated into assessment tools to enhance the accuracy of detection.
Clarification of the relevance of other neurocognitive disorders (e.g. dementia, MCI) upon clinical presentation of delirium, depression and 
overlap states.
Causation:
Investigation of the extent to which delirium and depression share risk factors and how pathophysiological mechanisms in these states overlap 
and relate to treatment and outcomes.
Treatment:
Therapeutic trials assessing the impact of various psychotropic agents (antidepressants, antipsychotics) specifically on mood disturbances 
occurring in delirium.
